998 Shares in Chemed Co. (NYSE:CHE) Purchased by Kestra Investment Management LLC

Kestra Investment Management LLC purchased a new position in Chemed Co. (NYSE:CHE - Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 998 shares of the company's stock, valued at approximately $600,000.

Several other large investors also recently bought and sold shares of the business. Caisse DE Depot ET Placement DU Quebec bought a new stake in Chemed in the third quarter worth $2,952,000. Crawford Fund Management LLC bought a new stake in Chemed in the third quarter worth $4,297,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in Chemed by 7.8% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 45,920 shares of the company's stock worth $27,597,000 after purchasing an additional 3,314 shares during the last quarter. Townsquare Capital LLC bought a new stake in Chemed in the third quarter worth $4,115,000. Finally, BNP Paribas Financial Markets increased its position in Chemed by 36.2% in the third quarter. BNP Paribas Financial Markets now owns 26,381 shares of the company's stock worth $15,854,000 after purchasing an additional 7,007 shares during the last quarter. Institutional investors own 95.85% of the company's stock.

Insider Transactions at Chemed

In related news, EVP Spencer S. Lee sold 732 shares of the company's stock in a transaction dated Wednesday, November 27th. The shares were sold at an average price of $575.62, for a total value of $421,353.84. Following the completion of the sale, the executive vice president now directly owns 18,287 shares of the company's stock, valued at $10,526,362.94. This represents a 3.85 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the company's stock in a transaction dated Monday, November 25th. The stock was sold at an average price of $572.77, for a total transaction of $1,145,540.00. Following the completion of the sale, the chief executive officer now directly owns 101,735 shares of the company's stock, valued at approximately $58,270,755.95. This trade represents a 1.93 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 6,845 shares of company stock worth $3,978,798. Insiders own 3.32% of the company's stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on CHE shares. Royal Bank of Canada reduced their price target on shares of Chemed from $697.00 to $633.00 and set an "outperform" rating on the stock in a research report on Tuesday, November 5th. StockNews.com upgraded shares of Chemed from a "hold" rating to a "buy" rating in a research report on Saturday.

Chemed Stock Performance

CHE stock traded down $0.88 during mid-day trading on Monday, reaching $571.51. 23,065 shares of the stock traded hands, compared to its average volume of 85,696. Chemed Co. has a one year low of $523.33 and a one year high of $654.62. The stock has a market capitalization of $8.60 billion, a PE ratio of 28.84, a PEG ratio of 2.43 and a beta of 0.46. The business has a 50-day moving average price of $578.27 and a two-hundred day moving average price of $565.05.

Chemed (NYSE:CHE - Get Free Report) last posted its quarterly earnings data on Tuesday, October 29th. The company reported $5.64 earnings per share for the quarter, missing analysts' consensus estimates of $5.76 by ($0.12). Chemed had a net margin of 12.69% and a return on equity of 27.86%. The firm had revenue of $606.18 million for the quarter, compared to the consensus estimate of $612.22 million. During the same quarter last year, the firm earned $5.32 EPS. The company's revenue was up 7.4% on a year-over-year basis. On average, equities analysts expect that Chemed Co. will post 21.43 earnings per share for the current fiscal year.

Chemed Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, December 6th. Stockholders of record on Monday, November 18th will be issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.35%. The ex-dividend date is Monday, November 18th. Chemed's payout ratio is presently 10.11%.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.